Q2 2024 |
4 |
$305M |
+$9.16K |
-$19M |
-$19M |
CNSL, LILAK, UNIT, LILA
|
13F-HR |
8/14/2024, 06:25 AM |
Q1 2024 |
4 |
$296M |
+$294K |
$0 |
+$294K |
CNSL, LILAK, UNIT, LILA
|
13F-HR |
5/15/2024, 08:15 AM |
Q4 2023 |
4 |
$302M |
+$27.5K |
$0 |
+$27.5K |
CNSL, LILAK, UNIT, LILA
|
13F-HR |
2/14/2024, 12:58 PM |
Q3 2023 |
4 |
$272M |
+$27.5K |
$0 |
+$27.5K |
CNSL, LILAK, UNIT, LILA
|
13F-HR |
11/14/2023, 12:12 PM |
Q2 2023 |
4 |
$294M |
+$161K |
-$8.33M |
-$8.17M |
CNSL, LILAK, UNIT, LILA
|
13F-HR |
8/14/2023, 01:16 PM |
Q1 2023 |
5 |
$244M |
+$157K |
-$10.3M |
-$10.1M |
LILAK, CNSL, UNIT, MCS, LILA
|
13F-HR |
5/15/2023, 11:12 AM |
Q4 2022 |
5 |
$290M |
+$27.5K |
-$3.18M |
-$3.15M |
CNSL, LILAK, UNIT, MCS, LILA
|
13F-HR |
2/14/2023, 10:03 AM |
Q3 2022 |
6 |
$301M |
+$27.5K |
-$1.16M |
-$1.13M |
CNSL, LILAK, UNIT, MCS, FOUR
|
Restatement |
11/15/2022, 09:29 PM |
Q2 2022 |
7 |
$450M |
+$404K |
-$3.74M |
-$3.34M |
CNSL, LILAK, UNIT, MCS, HMTV
|
13F-HR |
8/15/2022, 12:37 PM |
Q1 2022 |
7 |
$460M |
+$273K |
-$26.9M |
-$26.6M |
CNSL, LILAK, UNIT, MCS, FOUR
|
13F-HR |
5/16/2022, 06:53 AM |
Q4 2021 |
7 |
$283M |
+$27.5K |
-$133K |
-$105K |
LILAK, UNIT, MCS, HMTV, FOUR
|
13F-HR |
2/14/2022, 08:42 AM |
Q3 2021 |
7 |
$355M |
+$226K |
-$15.3M |
-$15.1M |
LILAK, UNIT, CNSL, MCS, HMTV
|
Restatement |
11/16/2021, 04:23 PM |
Q2 2021 |
9 |
$375M |
+$11.2M |
-$118M |
-$107M |
LILAK, UNIT, CNSL, MCS, MIC
|
13F-HR |
8/16/2021, 08:18 AM |
Q1 2021 |
9 |
$456M |
+$5.94M |
-$175M |
-$169M |
LILAK, RXT, UNIT, CNSL, MCS
|
13F-HR |
5/17/2021, 10:22 AM |
Q4 2020 |
10 |
$524M |
+$286M |
-$242K |
+$286M |
RXT, LILAK, UNIT, CNSL, MCS
|
13F-HR |
2/16/2021, 11:44 AM |
Q3 2020 |
5 |
$188M |
+$26.2M |
-$5.87M |
+$20.3M |
LILAK, UNIT, HMTV, ENT, LILA
|
13F-HR |
11/16/2020, 08:21 AM |
Q2 2020 |
5 |
$201M |
+$222K |
-$9.59M |
-$9.36M |
LILAK, UNIT, ENT, HMTV, LILA
|
13F-HR |
8/14/2020, 02:20 PM |
Q1 2020 |
7 |
$162M |
+$5.67M |
$0 |
+$5.67M |
LILAK, UNIT, ARMK, PENN, HMTV
|
13F-HR |
5/15/2020, 07:21 AM |
Q4 2019 |
5 |
$277M |
+$320K |
-$1.25M |
-$930K |
LILAK, UNIT, ENT, HMTV, LILA
|
13F-HR |
2/14/2020, 07:14 AM |
Q3 2019 |
6 |
$250M |
+$4.23M |
$0 |
+$4.23M |
LILAK, UNIT, ENT, PCG, HMTV
|
13F-HR |
11/14/2019, 09:08 AM |
Q2 2019 |
6 |
$261M |
+$23M |
$0 |
+$23M |
LILAK, UNIT, ENT, PCG, HMTV
|
13F-HR |
8/14/2019, 10:00 AM |
Q1 2019 |
6 |
$271M |
+$2.25M |
-$109M |
-$107M |
LILAK, UNIT, PCG, ENT, HMTV
|
13F-HR |
5/15/2019, 08:11 AM |
Q4 2018 |
6 |
$365M |
+$150M |
-$9.36K |
+$150M |
LILAK, UNIT, GLIBA, ENT, HMTV
|
13F-HR |
2/14/2019, 06:20 AM |
Q3 2018 |
4 |
$273M |
+$23.5M |
$0 |
+$23.5M |
UNIT, GLIBA, LILAK, HMTV
|
13F-HR |
11/14/2018, 10:19 AM |
Q2 2018 |
3 |
$236M |
+$221K |
-$110M |
-$110M |
UNIT, GLIBA, HMTV
|
13F-HR |
8/14/2018, 10:24 AM |
Q1 2018 |
3 |
$314M |
+$108M |
-$119M |
-$11M |
UNIT, GLIBA, HMTV
|
13F-HR |
5/15/2018, 10:13 AM |
Q4 2017 |
4 |
$345M |
+$27.1M |
$0 |
+$27.1M |
UNIT, GNCMA, LVNTA, HMTV
|
13F-HR |
2/14/2018, 08:00 AM |
Q3 2017 |
3 |
$289M |
+$16.6M |
$0 |
+$16.6M |
UNIT, GNCMA, LVNTA
|
13F-HR |
11/14/2017, 11:44 AM |
Q2 2017 |
3 |
$365M |
+$50.2M |
$0 |
+$50.2M |
UNIT, GNCMA, LVNTA
|
13F-HR |
8/14/2017, 10:01 AM |
Q1 2017 |
2 |
$294M |
+$259M |
-$254M |
+$4.4M |
UNIT, GNCMA
|
13F-HR |
7/24/2017, 05:21 PM |
Q4 2016 |
2 |
$288M |
$0 |
$0 |
|
CSAL, GNCMA
|
13F-HR |
2/14/2017, 12:54 PM |